These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

999 related items for PubMed ID: 19176597

  • 1. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y.
    Cardiovasc Res; 2009 May 01; 82(2):371-81. PubMed ID: 19176597
    [Abstract] [Full Text] [Related]

  • 2. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.
    Circulation; 2007 Sep 18; 116(12):1404-12. PubMed ID: 17724261
    [Abstract] [Full Text] [Related]

  • 3. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 4. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR, Moulton KS, Kazlauskas A.
    Circ Res; 2007 Aug 17; 101(4):357-67. PubMed ID: 17615372
    [Abstract] [Full Text] [Related]

  • 5. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 6. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C, Preusch MR, Hofmann G, Morris-Rosenfeld S, Blessing E, Rosenfeld ME, Katus HA, Bea F.
    Cardiovasc Res; 2010 May 01; 86(2):321-9. PubMed ID: 20110335
    [Abstract] [Full Text] [Related]

  • 7. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 8. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
    Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L, Beger R, Hermonat PL, Thomas M, Sawamura T.
    Circ Res; 2007 Jun 08; 100(11):1634-42. PubMed ID: 17478727
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
    Inoue K, Arai Y, Kurihara H, Kita T, Sawamura T.
    Circ Res; 2005 Jul 22; 97(2):176-84. PubMed ID: 15961718
    [Abstract] [Full Text] [Related]

  • 10. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW, Hasu M, MacLaren R, Thabet M, Raizman JE, Veinot JP, Marcel YL, Milne RW, Whitman SC.
    Cardiovasc Pathol; 2013 Jul 22; 22(6):458-64. PubMed ID: 23684818
    [Abstract] [Full Text] [Related]

  • 11. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, Sawamura T, Mehta JL.
    Cardiovasc Res; 2008 Jul 15; 79(2):287-93. PubMed ID: 18453637
    [Abstract] [Full Text] [Related]

  • 12. FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.
    Zhang Y, Wang X, Vales C, Lee FY, Lee H, Lusis AJ, Edwards PA.
    Arterioscler Thromb Vasc Biol; 2006 Oct 15; 26(10):2316-21. PubMed ID: 16825595
    [Abstract] [Full Text] [Related]

  • 13. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW, Lusis AJ, Kabarowski JH.
    Arterioscler Thromb Vasc Biol; 2006 Dec 15; 26(12):2703-9. PubMed ID: 16990555
    [Abstract] [Full Text] [Related]

  • 14. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice.
    Jagavelu K, Tietge UJ, Gaestel M, Drexler H, Schieffer B, Bavendiek U.
    Circ Res; 2007 Nov 26; 101(11):1104-12. PubMed ID: 17885219
    [Abstract] [Full Text] [Related]

  • 15. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR, Yancey PG, Ryzhov SV, Kon V, Breyer MD, Magnuson MA, Fazio S, Linton MF.
    Arterioscler Thromb Vasc Biol; 2005 Aug 26; 25(8):1647-53. PubMed ID: 15947238
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P, Pospisilova N, Jamborova G, Pospechova K, Solichova D, Andrys C, Zdansky P, Micuda S, Semecky V.
    Life Sci; 2008 Mar 26; 82(13-14):708-17. PubMed ID: 18289605
    [Abstract] [Full Text] [Related]

  • 17. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
    Hodgkinson CP, Laxton RC, Patel K, Ye S.
    Arterioscler Thromb Vasc Biol; 2008 Dec 26; 28(12):2275-81. PubMed ID: 18818414
    [Abstract] [Full Text] [Related]

  • 18. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2006 Aug 26; 26(8):1858-63. PubMed ID: 16763157
    [Abstract] [Full Text] [Related]

  • 19. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M.
    Hypertens Res; 2006 Jun 26; 29(6):457-66. PubMed ID: 16940709
    [Abstract] [Full Text] [Related]

  • 20. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S, Blessing E, Preusch MR, Albrecht C, Bierhaus A, Andrassy M, Nawroth PP, Rosenfeld ME, Katus HA, Bea F.
    Eur J Clin Invest; 2011 Nov 26; 41(11):1164-71. PubMed ID: 21418204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.